Acute myeloid leukaemia (AML) is an aggressive blood cancer of myeloid cells.
Risk increases with age, and AML is most common in people over 65.
Chemotherapy is the mainstay of treatment, but bone marrow or stem cell transplants may also be considered.
Cancer Research UK - AML
©2022 Royal College of Physicians of Edinburgh
A charity registered in Scotland no. SC009465